Basra Sukhdeep, Szerlip Molly
Department of Cardiology, The Heart Hospital Baylor Plano, 110 Allied Drive, Plano, TX 75093, USA.
Department of Cardiology, The Heart Hospital Baylor Plano, 110 Allied Drive, Plano, TX 75093, USA.
Interv Cardiol Clin. 2017 Jul;6(3):373-386. doi: 10.1016/j.iccl.2017.03.007.
Valvular heart diseases such as aortic stenosis and mitral regurgitation are often associated with heart failure, which in turn increases patients' Surgical Thoracic Society (STS) score. A high STS score means the patient is high risk for surgical aortic valve replacement and mitral valve repair/replacement. Transcatheter aortic valve replacement and percutaneous mitral valve repair offer a minimally invasive alternative for the treatment of valvular heart disease in patients with severe heart failure. We aim to review the current evidence on the safety, efficacy, and outcomes of these devices in patients with severe heart failure.
诸如主动脉瓣狭窄和二尖瓣反流等心脏瓣膜疾病常与心力衰竭相关，而心力衰竭反过来又会增加患者的胸外科医师协会（STS）评分。高STS评分意味着患者进行主动脉瓣置换手术和二尖瓣修复/置换手术的风险很高。经导管主动脉瓣置换术和经皮二尖瓣修复术为治疗重度心力衰竭患者的心脏瓣膜疾病提供了一种微创替代方案。我们旨在综述有关这些器械在重度心力衰竭患者中的安全性、有效性和治疗结果的现有证据。
